Characterization of ascites-derived aldehyde dehydrogenase–positive ovarian cancer stem cells isolated from Leghorn chickens
暂无分享,去创建一个
[1] J. Takagi,et al. Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression. , 2018, Cell stem cell.
[2] Hans Clevers,et al. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity , 2018, Cell.
[3] Bon-Kyoung Koo,et al. Human Primary Liver Cancer -derived Organoid Cultures for disease modelling and drug screening , 2017, Nature Medicine.
[4] Qiulian Wu,et al. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo. , 2016, Cancer research.
[5] Shiladitya Sengupta,et al. Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype , 2015, Nature Communications.
[6] Holger Weber,et al. Endothelial cell spheroids as a versatile tool to study angiogenesis in vitro , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] Patricia A. Johnson,et al. Expression of Adiponectin and Its Receptors Is Altered in Epithelial Ovarian Tumors and Ascites-Derived Ovarian Cancer Cell Lines , 2014, International Journal of Gynecologic Cancer.
[8] R. Ramachandran,et al. Aquaporin 5 expression is altered in ovarian tumors and ascites-derived ovarian tumor cells in the chicken model of ovarian tumor , 2014, Journal of Ovarian Research.
[9] D. Matei,et al. Epithelial ovarian cancer experimental models , 2014, Oncogene.
[10] Baocun Sun,et al. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma. , 2014, Gynecologic oncology.
[11] Tsuyoshi Saito,et al. Ovarian Cancer Stem Cells Are Enriched in Side Population and Aldehyde Dehydrogenase Bright Overlapping Population , 2013, PloS one.
[12] Rui Li,et al. Slug promoted vasculogenic mimicry in hepatocellular carcinoma , 2013, Journal of cellular and molecular medicine.
[13] Tsuyoshi Saito,et al. ALDH1-High Ovarian Cancer Stem-Like Cells Can Be Isolated from Serous and Clear Cell Adenocarcinoma Cells, and ALDH1 High Expression Is Associated with Poor Prognosis , 2013, PloS one.
[14] Patricia A. Johnson,et al. The hen as a model of ovarian cancer , 2013, Nature Reviews Cancer.
[15] Xuefeng Liu,et al. Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma , 2013, Medical Oncology.
[16] G. Enikolopov,et al. Ovarian surface epithelium at the junction area contains cancer-prone stem cell niche , 2013, Nature.
[17] T. Cooper,et al. Characterization of Ascites-Derived Ovarian Tumor Cells from Spontaneously Occurring Ovarian Tumors of the Chicken: Evidence for E-Cadherin Upregulation , 2013, PLoS ONE.
[18] Baocun Sun,et al. HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma , 2012, Journal of cellular and molecular medicine.
[19] Gema Moreno-Bueno,et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.
[20] Yu‐Chi Wang,et al. Tumorigenesis and Neoplastic Progression ALDH 1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD 44 Expression , Drug Resistance , and Poor Clinical Outcome , 2012 .
[21] Ronald D. Alvarez,et al. Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer , 2011, Clinical Cancer Research.
[22] Xiaoying Wang,et al. Role of hCG in Vasculogenic Mimicry in OVCAR-3 Ovarian Cancer Cell Line , 2011, International Journal of Gynecologic Cancer.
[23] K. Griffith,et al. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. , 2011, Cancer research.
[24] Lin Zhang,et al. Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers , 2010, PloS one.
[25] G. Mor,et al. Stem‐Like Ovarian Cancer Cells Can Serve as Tumor Vascular Progenitors , 2009, Stem cells.
[26] P. Bitterman,et al. Histopathology of Ovarian Tumors in Laying Hens: A Preclinical Model of Human Ovarian Cancer , 2009, International Journal of Gynecologic Cancer.
[27] M. Noble,et al. Cancer stem cells. , 2006, The New England journal of medicine.
[28] A. Skubitz,et al. Disaggregation and invasion of ovarian carcinoma ascites spheroids , 2006, Journal of Translational Medicine.
[29] S. Bapat,et al. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. , 2005, Cancer research.
[30] W. Grizzle,et al. A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis. , 2002, Gynecologic oncology.
[31] M. Hendrix,et al. Molecular determinants of ovarian cancer plasticity. , 2001, The American journal of pathology.
[32] P. Meltzer,et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.
[33] R. Kramer,et al. E-cadherin Regulates Anchorage-independent Growth and Survival in Oral Squamous Cell Carcinoma Cells* , 1998, The Journal of Biological Chemistry.
[34] T. Fredrickson. Ovarian tumors of the hen. , 1987, Environmental health perspectives.
[35] M. Piver,et al. Isolation and morphologic characterization of human ovarian carcinoma cell clusters present in effusions. , 1987, Experimental cell biology.
[36] B. Zetter,et al. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein , 1984, The Journal of cell biology.
[37] L. Ch,et al. Etiology of cancer of the human ovary: a review. , 1974 .
[38] C. Lingeman. Etiology of cancer of the human ovary: a review. , 1974, Journal of the National Cancer Institute.
[39] M F Fathalla,et al. Incessant ovulation--a factor in ovarian neoplasia? , 1971, Lancet.
[40] J. G. Campbell. Some Unusual Gonadal Tumours of the Fowl , 1951, British Journal of Cancer.